Nebula Genomics
Direct-to-consumer whole genome sequencing company co-founded by geneticist George Church, emphasizing privacy-preserving analysis of genomic data. Acquired by ProPhase Labs in 2021.
Website
https://www.nebula.orgLocation
San Francisco, California, USA
Founded
2018
Investors
1
Categories
genomics-sequencing, consumer-genomics, privacy, whole-genome-sequencing
Notes
Nebula Genomics was a pioneering direct-to-consumer genomics company that offered affordable whole genome sequencing services with a strong emphasis on privacy-preserving genomic data analysis. Co-founded by renowned geneticist George Church of Harvard Medical School, the company aimed to democratize access to complete genomic information while protecting user privacy.
The company was acquired by ProPhase Labs in August 2021 for approximately $14.6 million. Nebula continues to offer whole genome sequencing services under the ProPhase Labs umbrella.
Team
- George Church, Ph.D. - Co-Founder (Harvard Medical School)
- Kamal Obbad - Co-Founder & Former CEO
- Dennis Grishin, Ph.D. - Co-Founder & Former CSO
Additional Research Findings
- Founded in 2018
- Original headquarters in San Francisco, California
- Seed funding: $4.3 million in August 2018, led by Khosla Ventures
- Acquired by ProPhase Labs in August 2021 for ~$14.6 million
- Co-founded by George Church (Harvard geneticist)
- Privacy-preserving genomics approach
- Direct-to-consumer whole genome sequencing
- Blockchain-based data sharing concepts
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Khosla Ventures | Menlo Park, California, USA | generalist | seedseries-a+3 | 2 |